Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen reacquires rights to three drugs from Glaxo in 48 countries
Amgen reacquires rights to three drugs from Glaxo in 48 countries
Amgen reacquires rights to three drugs from Glaxo in 48 countries
Submitted by
admin
on December 14, 2015 - 10:42pm
Source:
Yahoo/Reuters
News Tags:
Amgen
GSK
Prolia
Vectibix
Xgeva
Headline:
Amgen reacquires rights to three drugs from Glaxo in 48 countries
Do Not Allow Advertisers to Use My Personal information
